Novozymes A-S Aktie

55,70EUR 0,54EUR 0,98%
Novozymes A-S hier für 0 Euro handeln mit finanzen.net zero
WKN DE: A1JP9Y / ISIN: DK0060336014
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 6 185 6 527 6 781 6 756 10 582
Umsatz pro Mitarbeiter in Mio. EUR 2,27 2,29 2,59 2,65 2,70

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 6 911 7 823 9 241 9 462 14 015
Summe Anlagevermögen 16 105 18 015 20 786 21 759 96 742
Summe Aktiva 21 026 25 228 28 013 28 594 120 632

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Gesamtverschuldung/ -verbindlichkeiten 4 872 6 188 6 949 7 781 13 399
Summe Fremdkapital 9 782 13 022 13 785 14 243 37 290
Summe Eigenkapital 11 244 12 206 14 228 14 351 83 342
Summe Passiva 21 026 25 228 28 013 28 594 120 632

Adresse

Biologiens Vej 2, 2800 Lyngby
Internet http://www.novonesis.com

Management

Anders Lund
Chief Operating Officer
Cees de Jong
Chairman
Claus Crone Fuglsang
Chief Scientific Officer
Ester Baiget
President & Chief Executive Officer
Frederikke Rose Spenner
Director
Heine Dalsgaard
Non-Independent Director
Henrik Joerck Nielsen
Executive VP-Strategy & Integration
Jens Kolind
Senior Vice President
Kasim Kutay
Non-Independent Director
Kevin Lane
Independent Director
Kim Stratton
Independent Director
Lars Bo Koppler
Director
Lise Kaae
Independent Director
Monila Kothari
Independent Director
Morten Enggaard Rasmussen
Executive VP-People & Stakeholder Relations
Morten Otto Alexander Sommer
Independent Director
Preben Nielsen
Director
Rainer Lehmann
Chief Financial Officer
Robert Noddeskov Jensen
Director
Tobias Cornelius Bjorklund
Head-Investor Relations
Winnie Hojvang Bügel
Head-Legal & General Counsel